Sudden waves of heat and sweating caused by losing testosterone: the commonest complaint on hormone therapy for prostate cancer.
They range from under three minutes of feeling warm to hours of sweating that needs a change of clothes or bedding, and they often disturb sleep. NICE NG131 offers medroxyprogesterone 20 mg a day for an initial 10 weeks and then evaluates it, with cyproterone acetate 50 mg twice a day for 4 weeks as the second option. In a randomised trial of 309 men, the median daily hot-flush score fell by 83.7 percent on medroxyprogesterone, 94.5 percent on cyproterone and 47.2 percent on venlafaxine at one month.
Shares Intermittent androgen deprivation (IAD), Prostate cancer.
Shares Intermittent androgen deprivation (IAD), Prostate cancer.
Shares Intermittent androgen deprivation (IAD), Prostate cancer.
Shares Intermittent androgen deprivation (IAD), Prostate cancer.
Shares Intermittent androgen deprivation (IAD), Prostate cancer.
Shares Intermittent androgen deprivation (IAD), Prostate cancer.
Shares Intermittent androgen deprivation (IAD), Prostate cancer.
Shares Intermittent androgen deprivation (IAD), Prostate cancer.